[ad_1]
MANKATO, Minnesota (FOX 9) – A Hy-Vee pharmacy in Mankato, Minnesota incorrectly administered the COVID-19 vaccine to 62 patients, according to a statement from Hy-Vee.
Staff at the Riverfront Hy-Vee pharmacy diluted the Pfizer vaccine with an injection of sterile water instead of the saline diluent provided by Pfizer.
So far, affected patients have reported no side effects. Hy-Vee consulted independent doctors, who said there was “no reason for medical concern.”
Hy-Vee has contacted those affected, including Greg Brown, 66, of Champlin, who received his first dose of the vaccine on Tuesday at the pharmacy. Now he is waiting for answers.
“We have been on the phone with Pfizer for over two hours, awaiting a response from Pfizer,” Brown said. “Well, they say, we don’t have enough data. It hasn’t been studied. No data at all.”
According to the Minnesota Department of Health, Brown and other affected patients likely won’t need to be revaccinated or vaccinated, but are waiting to hear from the CDC and Pfizer.
While Brown says the wait for clarity is baffling, he doesn’t want his experience to scare others away from getting the shot.
“Everyone needs a shot, mistakes happen, there are no potentially fatal injuries,” Brown said. “I’m just not comfortable with” Oh, a pharmacist will answer you. “No, that’s not acceptable at the moment.”
According to Hy-Vee, all of the pharmacy staff at Riverfront Hy-Vee have been retrained on how to administer the vaccine.
Hy-Vee’s full statement:
Hy-Vee recently received reports that our Riverfront Hy-Vee pharmacy in Mankato forgot to administer the first dose of Pfizer COVID-19 vaccine to 62 patients. Two pharmacy staff used vaccines mixed with sterile water injection diluent – which is commonly used to dilute injections, rather than the saline diluent supplied by Pfizer. After consulting with several third party doctors working on the vaccination process, we received confirmation that there is no reason for medical concern. No patient also reported side effects.
As soon as we were made aware of the incident, we began to personally call the affected patients. We have contacted the manufacturer and are working with each of the patients on the next steps. We have also reported this information to the appropriate regulatory authorities and have re-trained all of our pharmacy staff there.
We remain committed to playing an important role in delivering the COVID-19 vaccine to our local communities.
[ad_2]
Source link